Literature DB >> 16361309

Inhibitory effects of Lactobacillus reuteri on visceral pain induced by colorectal distension in Sprague-Dawley rats.

T Kamiya1, L Wang, P Forsythe, G Goettsche, Y Mao, Y Wang, G Tougas, J Bienenstock.   

Abstract

BACKGROUND AND AIMS: Probiotic bacteria are being investigated as possible treatments for many intestinal disorders. The present study aimed to explore the effects of live, heat killed, or gamma irradiated Lactobacillus reuteri on cardio-autonomic response and single fibre unit discharge in dorsal root ganglia to colorectal distension in healthy Sprague-Dawley rats housed under conventional conditions. The effects of this treatment on somatic pain were also examined.
METHODS: 1x10(9) bacteria were given by gavage for nine days. Colorectal distension occurred under anaesthesia. Heart rate was measured through continuous electrocardiography. Single fibre unit discharge was recorded from the 6th left lumbar dorsal root ganglion. Somatic pain was evaluated by the tail flick and paw pressure tests.
RESULTS: Colorectal distension caused a pressure dependent bradycardia in the control (native medium) group. Treatment with live, heat killed, or gamma irradiated bacteria as well as their products (conditioned medium) prevented the pain response even during the maximum distension pressure (80 mm Hg). Both viable and non-viable bacteria significantly decreased dorsal root ganglion single unit activity to distension. No effects on somatic pain were seen with any treatment.
CONCLUSIONS: Oral administration of either live or killed probiotic bacteria or conditioned medium inhibited the constitutive cardio-autonomic response to colorectal distension in rats through effects on enteric nerves. These data may provide a novel explanation for beneficial probiotic effects on visceral pain.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16361309      PMCID: PMC1856513          DOI: 10.1136/gut.2005.070987

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  47 in total

1.  Pseudoaffective cardioautonomic responses to gastric distension in rats.

Authors:  G Tougas; L Wang
Journal:  Am J Physiol       Date:  1999-07

2.  Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice.

Authors:  K L Madsen; J S Doyle; L D Jewell; M M Tavernini; R N Fedorak
Journal:  Gastroenterology       Date:  1999-05       Impact factor: 22.682

3.  Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles.

Authors:  Liam O'Mahony; Jane McCarthy; Peter Kelly; George Hurley; Fangyi Luo; Kersang Chen; Gerald C O'Sullivan; Barry Kiely; J Kevin Collins; Fergus Shanahan; Eamonn M M Quigley
Journal:  Gastroenterology       Date:  2005-03       Impact factor: 22.682

4.  Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial.

Authors:  B J Rembacken; A M Snelling; P M Hawkey; D M Chalmers; A T Axon
Journal:  Lancet       Date:  1999-08-21       Impact factor: 79.321

5.  Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis.

Authors:  A Venturi; P Gionchetti; F Rizzello; R Johansson; E Zucconi; P Brigidi; D Matteuzzi; M Campieri
Journal:  Aliment Pharmacol Ther       Date:  1999-08       Impact factor: 8.171

6.  Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids.

Authors:  Corinne Grangette; Sophie Nutten; Emmanuelle Palumbo; Siegfried Morath; Corinna Hermann; Joelle Dewulf; Bruno Pot; Thomas Hartung; Pascal Hols; Annick Mercenier
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-28       Impact factor: 11.205

7.  Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents.

Authors:  Zvi Weizman; Ghaleb Asli; Ahmed Alsheikh
Journal:  Pediatrics       Date:  2005-01       Impact factor: 7.124

8.  Colonic responses to Lactobacillus farciminis treatment in trinitrobenzene sulphonic acid-induced colitis in rats.

Authors:  F Lamine; H Eutamène; J Fioramonti; L Buéno; V Théodorou
Journal:  Scand J Gastroenterol       Date:  2004-12       Impact factor: 2.423

9.  Predominant symptoms in irritable bowel syndrome correlate with specific autonomic nervous system abnormalities.

Authors:  A Aggarwal; T F Cutts; T L Abell; S Cardoso; B Familoni; J Bremer; J Karas
Journal:  Gastroenterology       Date:  1994-04       Impact factor: 22.682

10.  Altered rectal perception is a biological marker of patients with irritable bowel syndrome.

Authors:  H Mertz; B Naliboff; J Munakata; N Niazi; E A Mayer
Journal:  Gastroenterology       Date:  1995-07       Impact factor: 22.682

View more
  66 in total

Review 1.  Voices from within: gut microbes and the CNS.

Authors:  Paul Forsythe; Wolfgang A Kunze
Journal:  Cell Mol Life Sci       Date:  2012-05-27       Impact factor: 9.261

2.  99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: psycho-neuroimmunology and the intestinal microbiota: clinical observations and basic mechanisms.

Authors:  J Bienenstock; S Collins
Journal:  Clin Exp Immunol       Date:  2010-04       Impact factor: 4.330

Review 3.  What does irritable bowel syndrome share with non-alcoholic fatty liver disease?

Authors:  Antonella Scalera; Matteo Nicola Dario Di Minno; Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

Review 4.  Infection-induced viscerosensory signals from the gut enhance anxiety: implications for psychoneuroimmunology.

Authors:  Lisa E Goehler; Mark Lyte; Ronald P A Gaykema
Journal:  Brain Behav Immun       Date:  2007-04-10       Impact factor: 7.217

5.  Protease-Mediated Suppression of DRG Neuron Excitability by Commensal Bacteria.

Authors:  Jessica L Sessenwein; Corey C Baker; Sabindra Pradhananga; Megan E Maitland; Elaine O Petrof; Emma Allen-Vercoe; Curtis Noordhof; David E Reed; Stephen J Vanner; Alan E Lomax
Journal:  J Neurosci       Date:  2017-10-31       Impact factor: 6.167

Review 6.  Sensory neuron regulation of gastrointestinal inflammation and bacterial host defence.

Authors:  N Y Lai; K Mills; I M Chiu
Journal:  J Intern Med       Date:  2017-02-02       Impact factor: 8.989

Review 7.  Microbiota: a novel regulator of pain.

Authors:  Manon Defaye; Sandie Gervason; Christophe Altier; Jean-Yves Berthon; Denis Ardid; Edith Filaire; Frédéric Antonio Carvalho
Journal:  J Neural Transm (Vienna)       Date:  2019-09-24       Impact factor: 3.575

8.  Toll-like receptors 3, 4, and 7 are expressed in the enteric nervous system and dorsal root ganglia.

Authors:  Isabella Barajon; Graziano Serrao; Francesca Arnaboldi; Emanuela Opizzi; Gerlomina Ripamonti; Andrea Balsari; Cristiano Rumio
Journal:  J Histochem Cytochem       Date:  2009-06-22       Impact factor: 2.479

Review 9.  Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.

Authors:  Eleonora Distrutti; Lorenzo Monaldi; Patrizia Ricci; Stefano Fiorucci
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

Review 10.  Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders.

Authors:  Diego Currò; Gianluca Ianiro; Silvia Pecere; Stefano Bibbò; Giovanni Cammarota
Journal:  Br J Pharmacol       Date:  2016-10-25       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.